Influence of antimicrobial consumption on gram-negative bacteria in inpatients receiving antimicrobial resistance therapy from 2008-2013 at a tertiary hospital in Shanghai, China

American Journal of Infection Control

Volumn 43, Issue 4, 2015, Pages 358-364

  Guo, Wei ^a   He, Qian ^a   Wang, Zhiyong ^a   Wei, Min ^b   Yang, Zhangwei ^b   Du, Yin ^b   Wu, Cheng ^a   He, Jia ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Antimicrobial stewardship policy; Cross correlation analysis; Infection control; Resistance reversal; Time series analysis

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZTREONAM; CARBAPENEM DERIVATIVE; CEFACLOR; CEFDINIR; CEFOPERAZONE PLUS SULBACTAM; CEFOXITIN; CEFPIROME; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; IMIPENEM; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; PENICILLANIC ACID; PIPERACILLIN; QUINOLONE DERIVATIVE; TAZOBACTAM;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; CHINA; CORRELATION ANALYSIS; DRUG USE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HUMAN; KLEBSIELLA PNEUMONIAE; NONHUMAN; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; REVIEW; TERTIARY CARE CENTER; ANALOGS AND DERIVATIVES; CROSS INFECTION; DRUG EFFECTS; EPIDEMIOLOGY; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITAL PATIENT; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; CEFTAZIDIME; CHINA; CIPROFLOXACIN; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG UTILIZATION REVIEW; ESCHERICHIA COLI; FLUOROQUINOLONES; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INPATIENTS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PENICILLANIC ACID; PIPERACILLIN; PSEUDOMONAS AERUGINOSA; TERTIARY CARE CENTERS;

EID: 84933047732     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2014.12.010     Document Type: Article

References (24)

1. Fauci AS, Marston lD. The perpetual challenge of antimicrobial resistance. J Am Med Assoc 2014;311: 1853-4.
2. Yezli S, Li H. Antibiotic resistance amongst healthcare-associated pathogens in China. Int J Antimicrob Agents 2012;40: 389-97.
3. Heddini A, Cars O, Qiang S, Tomson G. Antibiotic resistance in Chinaea major future challenge. Lancet 2009;373: 30.
4. Xiao Y, Zhang J, Zheng B, Zhao L, Li S, Li L. Changes in Chinese policies to promote the rational use of antibiotics. PLoS Med 2013;10: E1001556.
5. Xiao Y, Li L. Legislation of clinical antibiotic use in China. Lancet Infect Dis 2013; 13: 189-91.
6. Yang L, Liu C, Ferrier JA, Zhou W, Zhang X. The impact of the National Essential Medicines Policy on prescribing behaviours in primary care facilities in Hubei province of China. Health Policy Plan 2013;28: 750-60.
7. Ministry of Health, People's Republic of China. Administrative regulations for clinical use of antibacterial agents. Ministry of Health: Beijing, China; May, 2012.
8. WHO. Guidelines for ATC Classification and DDD Assignment. WHO Collaborating Centre for Drug Statistics Methodology. Oslo, Norway: Norwegian Institute of Public Health; 2012.
9. Clinical and Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement. Document M100eS19. Wayne, PA: CLSI; 2009.
10. López-Lozano J-Ma, Monnet DL, Yagüe A, Burgos A, Gonzalo N, Campillos P, et al. Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: A time series analysis. Int J Antimicrob Agents 2000;14: 21-31.
11. Box GE, Jenkins GM. Time series analysis: Forecasting and control. revised ed. SanFrancisco, CA: Holden-Day; 1976.
12. Helfenstein U. Box-Jenkins modelling in medical research. Stat Methods Med Res 1996;5: 3-22.
13. Lee J, Oh CE, Choi EH, Lee HJ. The impact of the increased use of piperacillin/tazobactam on the selection of antibiotic resistance among invasive Escherichia coli and Klebsiella pneumoniae isolates. Int J Infect Dis 2013;17: E638-43.
14. Peterson LR. Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae: The role of piperacillin-tazobactam. Clin Microbiol Infect 2008;14(Suppl 1): 181-4.
15. Peterson LR. Squeezing the antibiotic balloon: The impact of antimicrobial classes on emerging resistance. Clin Microbiol Infect 2005;11(Suppl 5): 4-16.
16. Edelsberg J, Weycker D, Barron R, Li X, Wu H, Oster G, et al. Prevalence of antibiotic resistance in US hospitals. Diagn Microbiol Infect Dis 2014;78: 255-62.
17. Jean SS, Hsueh PR. High burden of antimicrobial resistance in Asia. Int J Antimicrob Agents 2011;37: 291-5.
18. Hocquet D, Bertrand X, Kohler T, Talon D, Plesiat P. Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone. Antimicrobial Agents Chemother 2003;47: 1887-94.
19. Paterson DL. "Collateral damage" from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis 2004;38(Suppl 4): S341-5.
20. Tängdén T. Multidrug-resistant Escherichia coli and Klebsiella pneumoniae: Treatment, selection and international spread. In: Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, 840. Uppsala: Acta Universitatis Upsaliensis; 2012. p. 72.
21. Andersson DI, Hughes D. Antibiotic resistance and its cost: Is it possible to reverse resistance? Nat Rev Microbiol 2010;8: 260-71.
22. Gallini A, Degris E, Desplas M, Bourrel R, Archambaud M, Montastruc JL, et al. Influence of fluoroquinolone consumption in inpatients and outpatients on ciprofloxacin-resistant Escherichia coli in a university hospital. J Antimicrob Chemother 2010;65: 2650-7.
23. Vernaz N, Huttner B, Muscionico D, Salomon J-L, Bonnabry P, López-Lozano JM, et al. Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using population-based data from a large hospital and its surrounding community. J Antimicrob Chemother 2011;66: 928-35.
24. Forsberg KJ, Reyes A, Wang B, Selleck EM, Sommer MO, Dantas G. The shared antibiotic resistome of soil bacteria and human pathogens. Science 2012;337: 1107-11.